Zero Trust: Enabling the Last Mile of Biomedical AI Research

Stephen Dennis ,
Stephen Dennis
Dr. Bob Rogers
Dr. Bob Rogers

Published: 14.01.2023.

Biochemistry

Volume 6, Issue 1 (2023)

https://doi.org/10.30953/bhty.v6.259

Abstract

Over 90% of all biomedical AI research is stalled due to its inability to access real world protected health information to complete the required clinical validation and valuation prior to its deployment.  With AI forecasted to improve patient outcomes by 40% and costs by 50% the new paradigm of zero trust must be adopted and leveraged to avoid the existential crisis facing biomedical AI research.  Join us and learn how confidential computing and blockchain meet the requirements of zero trust.    

Keywords

Citation

Copyright

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles